Journal of Affective Disorders
Volume 78, Issue 3 , Pages 201-208 , March 2004

Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis

  • François Curtin

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Dr. F. Curtin c/o Dr. P. Schulz, Clinical Psychopharmacology Unit, 2 Chemin du Petit-Bel-Air, CH-1225 Chêne-Bonry/Geneva, Switzerland. Tel.: +41-22-305-4111; fax: +41-22-305-5309
    • ,
  • Pierre Schulz

Received 12 March 2002 ,Revised 25 July 2002 ,Accepted 25 July 2002.

References 

  1. American Psychiatric Association. Practice Guidelines For the Treatment of Psychiatric Disorders. Washington DC: American Psychiatric Association; 2000; p. 521
  2. Appleton WS. Practical Clinical Psychopharmacology. 3rd Edition. Baltimore: Williams and Wilkins; 1988; p. 170
  3. Bottaı̈ T, Hüe B, Hillaire-Buys D, Barbe A, Alric R, Pouget R, et al. Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma. J. Affect. Dis. 1995;36:21–27
  4. Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double-blind of the effects of clonazepam and lorazepam in acute mania. J. Clin. Psychopharmacol. 1990;10:403–408
  5. Busch FN, Miller FT, Weiden PJ. A comparison of two adjunctive treatment strategies in acute mania. J. Clin. Psychiatry. 1989;50:453–455
  6. Chou JCY, Czobor P, Charles O, Tuma I, Winsberg B, Allen MH, et al. Acute mania: haloperidol dose and augmentation with lithium and lorazepam. J. Clin. Psychopharmacol. 1999;19:500–505
  7. Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol. Psychiatry. 1983;18:451–466
  8. Chouinard G, Annable L, Turnier L, Holobow N, Szkrumelak N. A double-blind randomized clinical trial of rapid tranquilization with IM clonazepam and IM haloperidol in agitated psychotic patients with manic symptoms. Can. J. Psychiatry. 1993;38(Suppl. 4):114–121
  9. Clark HM, Berk M, Brook S. A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Hum. Psychopharmacol. 1997;12:325–328
  10. De la Gandara Martin JJ, de Dios Francos A, Lopez Gomez I, Hernandez Herrero H, Redondo Martinez AL. Treatment of affective disorders with clonazepam [Spanish] Actas Luso. Esp. Neurol. Psiquiatr. Cienc. Afines. 1991;19:88–96
  11. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177–188
  12. Domenici F, Parmigiani G, Wolpert RL, Hasselblad V. Meta-analysis of migraine headache treatments: combining information from heterogeneous designs. J. Am. Statist. Assoc. 1999;94:16–28
  13. Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: a double blind trial. Aust. N.Z. J. Psychiatry. 1991;25:238–242
  14. Hedges LV. Distribution theory of Glass’s estimator of effect size and related estimators. J. Educ. Statistics. 1981;6:107–128
  15. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch. Gen. Psychiatry. 1982;39:473–481
  16. Lenox RH, Modell JG, Weiner S. Acute treatment of manic agitation with lorazepam. Psychosomatics. 1986;27:28–31
  17. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double blind study. J. Clin. Psychiatry. 1992;53:47–52
  18. Li Z, Begg CB. Random effects models for combining results from controlled and uncontrolled studies in meta-analyses. J. Am. Statist. Assoc. 1994;89:1523–1527
  19. Modell JG. Further experience and observations with lorazepam in the management of behavioral agitation. J. Clin. Psychopharmacol. 1986;6:385–387
  20. Modell JG, Lenox RH, Weiner S. Inpatient clinical trial of lorazepam for the management of manic agitation. J. Clin. Psychopharmacol. 1985;5:109–113
  21. Nowlin-Finch NL, Altschuler LL, Szuba MP, Mintz J. Rapid resolution of first episodes of mania: sleep related. J. Clin. Psychiatry. 1994;55:26–29
  22. Peet M, Pratt JP. Lithium. Current status in psychiatric disorders. Drugs. 1993;46:7–17
  23. Poolsup N, Li Wan Po A, de Oliveira IR. Systematic overview of lithium treatment in acute mania. J. Clin. Pharm. Ther. 2000;25:139–156
  24. Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch. Gen. Psychiatry. 1975;32:34–42
  25. Spiegelalter DJ, Thomas A, Best NG, Gilks WR. BUGS: Bayesian Inference Using Gibbs Sampling, Version. 0.5. Cambridge: MRC Biostatistics Unit; 1995;

PII: S0165-0327(02)00317-8

doi: 10.1016/S0165-0327(02)00317-8

Journal of Affective Disorders
Volume 78, Issue 3 , Pages 201-208 , March 2004

Article Tools

* Image Usage & Resolution